NEW YORK (GenomeWeb) – Abbott today said that its Diagnostics business revenues grew 47 percent year over year in the second quarter, driven by sales in its rapid diagnostics business, which reflect results for Alere acquired in October 2017.

On an organic basis, without rapid diagnostics sales, Abbott's worldwide diagnostics sales increased 7 percent, driven by strong core lab and MDx sales.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.